老虎證券

BRIEF-Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million

Reuters
02-18
BRIEF-Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million

Feb 18 (Reuters) - Chemours Co CC.N:

  • CHEMOURS: OUTLOOK FY ADJUSTED EBITDA BETWEEN $825 MILLION AND $975 MILLION

  • CHEMOURS: OUTLOOK FY CAPITAL EXPENDITURES BETWEEN $250 MILLION TO $300 MILLION

  • CHEMOURS: OUTLOOK Q1 CONSOLIDATED NET SALES TO BE FLAT TO SLIGHTLY DOWN SEQUENTIALLY

  • CHEMOURS: QTRLY NET SALES OF $1.4 BILLION

  • CHEMOURS: QTRLY ADJUSTED EPS $0.11

  • CHEMOURS: IN 2024, FULLY REMEDIATED ALL FOUR MATERIAL WEAKNESSES IN INTERNAL CONTROL PREVIOUSLY IDENTIFIED IN THE 2023 FORM 10-K

  • Q4 EARNINGS PER SHARE VIEW $0.12, REVENUE VIEW $1.36 BILLION -- LSEG IBES DATA

  • Q1 REVENUE VIEW $1.41 BILLION -- LSEG IBES DATA

Source text: ID:nBwb2qq3ha

Further company coverage: CC.N

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10